Alpha 1-Antitrypsin Deficiency - 59 Studies Found

Completed : Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
: Cystic Fibrosis
: 2012-09-06
:
  • Biological: Alpha-1 HC 100 mg

Completed : Alpha-1 Carrier Genomics Study
:
  • Alpha-1 Antitrypsin Deficiency
  • Emphysema
  • Emphysema
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cys
    : 2012-06-06
    :
    • Procedure: Transplantation of lungs obtained from Non-Heart-Beating Donors (
Terminated : Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
:
  • Emphysema
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cys
    : 2010-11-12
    :
    • Device: Steen Solution™

Not yet recruiting : Effects of Pulmonary Rehabilitation on Skeletal Muscle in COPD Patients
: Chronic Obstructive Pulmonary Disease
: 2016-09-21
: Procedure: Pulmonary rehabilitation 3-weeks of inpatient pulmonary Rehabilitation including exercise Tra
Withdrawn : A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II
: Diabetes Mellitus, Type 1
: 2010-08-16
:
  • Drug: Aralast NP Participants

NOT_YET_RECRUITING : Open Label Extension Study of INBRX-101 in Adults With AATD Emphysema
:
: 2024-11-01
: A1PI, Recombinant, Bivalent Fc Fusion Protein
NOT_YET_RECRUITING : A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
: Alpha 1-Antitrypsin Deficiency
: 2024-11-01
: Nebulized solution of KB408, a replication-defective HSV-1 vector expressing full length human SERPINA1
RECRUITING : Study of INBRX-101 Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema
: Alpha 1-Antitrypsin Deficiency
: 2024-11-01
: A1PI, Recombinant, Bivalent Fc Fusion Protein
<<< Previous